Ua hoʻokumu ʻo Shanghai i nā lāʻau lapaʻau kuʻuna Kina a me nā hoʻomākaukau maʻalahi a me ka lāʻau lapaʻau ʻole e kōkua i ka poʻe e hakakā i ka maʻi maʻi puna

1. Ua hoʻokumu ʻo Shanghai i nā lāʻau lapaʻau kuʻuna Kina a me ka hoʻomākaukau maʻalahi a me ka lāʻau lapaʻau ʻole e kōkua i ka poʻe e hakakā me ka maʻi maʻi puna.

Ua hōʻike ʻo Shanghai Municipal Administration of Traditional Chinese Medicine i ka lā 5 o ka National Base for the Prevention and Control of Chinese Medicine Epidemic Diseases (Shanghai) i alakaʻi i ka hoʻokumu ʻana i ka Chinese Medicine Prevention and Control Plan no ka 2023 Spring Influenza ma Shanghai (Trial) (i kapa ʻia ma hope aku ʻo ia ka hoʻolālā), noʻonoʻo i ka hoʻomaopopo ʻana i ka lāʻau lapaʻau Kina e pili ana i ka maʻi maʻi maʻi, hoʻokumu i nā lāʻau lapaʻau Kina no nā pākeke a me nā keiki e pili ana i ka ʻokoʻa o ka maʻi maʻi, a ua hoʻolaha i kekahi mau lāʻau lapaʻau kuʻuna Kina a me nā hoʻomākaukau maʻalahi a me nā lāʻau lapaʻau ʻole no ka pale ʻana a me ka mālama ʻana. .

I ka hoʻoilo a me ka pūnāwai, he mahana a me ke anuanu ka ʻokoʻa o ka mahana ma waena o ke ao a me ka pō, a ua komo nā maʻi maʻi maʻi i kahi kiʻekiʻe a me ka wā maʻi maʻi.I kēia mau lā, ua hoʻonui ʻia ka nui o nā maʻi me ka influenza A a me nā maʻi ʻē aʻe i loaʻa i nā haukapila nui ma Shanghai.Manaʻo ka papahana e hāʻawi i ka pāʻani piha i nā ʻano a me nā pono o ka lāʻau lapaʻau Kina ma ka pale ʻana a me ka mālama ʻana i ka maʻi maʻi maʻi.

ʻO Zhang Wei, kekahi o nā mea kākau o ka hoʻolālā, ka hope alakaʻi o ka COVID-19 Expert Group for Traditional Chinese Medicine Treatment and the director of the Pulmonary Disease Department of Shuguang Hospital, manaʻoʻiʻo ʻo ka ulu ʻana o ka maʻi influenza (influenza) ka hapa nui o ia iho. kaupalena ana.Hiki i kekahi mau keiki nāwaliwali a me nā poʻe ʻelemakule me nā maʻi lalo ke hoʻopilikia i nā pilikia ʻē aʻe ma muli o nā maʻi exogenous, ʻo ia ke kumu o ka pale ʻana a me ka mālama ʻana i nā lāʻau lapaʻau Kina a me nā lāʻau lapaʻau komohana.Ua haʻi ʻo ia i ka poʻe nūhou e manaʻoʻiʻo nei ka lāʻau lapaʻau kuʻuna Kina ʻo ka maʻi influenza i ke ʻano anu o kēia manawa.Wahi a ka ʻike kuʻuna, ʻo ka maʻi maʻi a me ka mālama ʻana e pili ana i ka ʻōnaehana ʻokoʻa syndrome a me nā ʻano lapaʻau o nā meridian ʻeono, ka ʻokoʻa maʻi o Weiqi a me Yingxue, a me ka ʻōnaehana ʻokoʻa syndrome a me ke ʻano o ka mālama ʻana o nā jiao ʻekolu, a me ka nānā ʻana. uku ʻia i ka noi hui ʻana o ka hoʻoikaika a me ka hoʻopau ʻana i nā kumu pathogenic ma nā pae a me nā pae.

"ʻO ka maʻi influenza ka hapa nui o ka maʻi maʻi a hiki ke ho'ōla ʻia i ka manawa pōkole ma hope o ka mālama ʻana i nā hōʻailona maʻamau a me ka hana TCM."Ua kuhikuhi ʻo Zhang Wei, ma waho aʻe o nā lāʻau lapaʻau kuʻuna Kina a me nā hoʻomākaukau maʻalahi i ʻōlelo ʻia i ka papahana, ua loaʻa i nā halemai TCM nui ma Shanghai ka ʻike waiwai i ka ʻike a me ka mālama ʻana i ka maʻi influenza, a me kahi ʻano o ka hoʻomākaukau ʻana i ka haukapila a me nā ʻōlelo kuhikuhi.

Ua hōʻike ʻia ʻo ka hoʻoili hou ʻana he H1N1 ka nui.Ke hoʻohālikelike ʻia me ke anu maʻamau, ʻoi aku ka maʻi maʻi, ʻoi aku ke kiʻekiʻe o ke kuni a lōʻihi ka lōʻihi, ʻoi aku ka maopopo o nā hōʻailona systemic, a ʻoi aku ka lōʻihi o ka maʻi.

ʻO Xue Zheng, ka mea kākau o ka Children's Program a me ka luna o ke Keʻena Pediatrics o Shanghai Municipal Hospital of Traditional Chinese Medicine, manaʻoʻiʻo ʻo nā keiki ʻōpio ma mua o 5 mau makahiki he maʻi i ka maʻi maʻi.Hiki i nā keiki ke loaʻa i ka maʻi influenza a loaʻa nā hōʻailona koʻikoʻi ma muli o ko lākou māmā palupalu.He hana maikaʻi loa ka lāʻau lapaʻau Kina kuʻuna i ka pale ʻana a me ka mālama ʻana i ka maʻi maʻi i loko o nā keiki, ʻoi aku ka maikaʻi o ka mālama ʻana i ka maʻi maʻi A, hiki ke kāohi i ka laha a me ka hohonu o ka maʻi, hoʻomaikaʻi wikiwiki i nā hōʻailona, ​​a he ākea ākea.Loaʻa i nā Pediatrics i nā halemai Kina a me Western nā hoʻomākaukau o ka haukapila makua i hoʻohana nui ʻia i ka lāʻau lapaʻau.

Ua hoʻokumu ke kumumanaʻo i ka palapala ʻaelike lāʻau lapaʻau Kina kahiko a me nā lāʻau lapaʻau kuʻuna Kina a me nā hoʻomākaukau maʻalahi no ka mālama ʻana i ka maʻi maʻi maʻi o nā keiki, a ua hoʻolauna pū i kahi ʻano o nā ʻano lapaʻau maʻalahi o waho o ka lāʻau lapaʻau Kina.Hiki i nā mākua ke hoʻokō i ka lāʻau lapaʻau kuʻuna Kina ma o nā ʻano lapaʻau o waho e like me ka dietotherapy, lomilomi, nā maka pepeiao, noi a me ka ʻala pendant therapy e kōkua i nā keiki e hoʻomaikaʻi wikiwiki i nā hōʻailona a hoʻōla koke i ke olakino.

2. Ua loaʻa i nā mea noiʻi ʻepekema kekahi ʻano o nā mea hana anti-hepatoma mai ka lāʻau lapaʻau Artemisia annua.

Ua hoʻolaha ka Kunming Institute of Botany, Chinese Academy of Sciences, i ka lā 21, ua loaʻa i ka hui noiʻi o Chen Jijun kahi moʻo o nā dimer sesquiterpene moʻolelo me ka hana anti ate maʻi maʻi mai ka lāʻau lapaʻau Artemisia scoparia.Ua paʻi hou ʻia nā hopena noiʻi pili i loko o ka puke pai kaulana honua Signal Transmission and Targeted Therapy.

ʻO ka maʻi maʻi ʻaʻai he maʻi ʻino ʻino e hoʻoweliweli koʻikoʻi i ke olakino kanaka.I kēlā me kēia makahiki, ʻoi aku ka nui o nā hihia hou o ka maʻi maʻi ate ma ka honua ma mua o 840000, a ʻo ka nui o nā make i hoʻokumu ʻia e ka maʻi ʻaʻai a hiki i 780000, ʻoiai e pili ana i ka 50% o nā hihia hou i Kina.I kēia manawa, aia ʻehā tyrosine kinase inhibitors, sorafenib, regafinil, lovatinib a me cabotinib, hoʻokahi vascular endothelial growth factor receptor 2 antagonist, ramolumab, a me ʻelua mau mea hoʻopiʻi PD-1, navumab a me pamuzumab, i hoʻohana ʻia i ka mālama ʻana i ka maʻi maʻi ate. , akā, he mea maʻalahi a maʻalahi keʻano hoʻolālā e hana i ka lāʻau kū'ē.

I nā makahiki i hala iho nei, ua kūpaʻa ka hui noiʻi o Chen Jijun i ka ʻimi ʻana i nā pūhui alakaʻi anti-hepatoma a me nā lāʻau lapaʻau hou me ke ʻano kūʻokoʻa a me nā ʻano hana hou o ka hana mai nā mea kanu Artemisia, a ua hoʻokumu maikaʻi i kahi ʻano hoʻokaʻawale e hui pū ana i ka ʻike kuhikuhi o nā dimer sesquiterpene ma Artemisia. nā mea kanu me ka nānā ʻana i ka hana anti-hepatoma.Ua ʻike ʻia kēia haʻawina no ka manawa mua i loaʻa i ka extract o Artemisia annua ka hana inhibitory ikaika ma nā ʻāpana hepatoma ʻekolu, a no ka manawa mua, 36 novel sesquiterpene dimers o 9 structural type - Artemisia annua A1-A3, B1-B2, C1-C4 , D, E, F1-F15, G1-G8, H a me au i kaawale mai ka mahele hana o Artemisia annua.

ʻO nā haʻawina hou aʻe i hōʻike ʻia ma waena o nā dimer sesquiterpene novel 36, ʻoi aku ka maikaʻi o ka hana o artemisinin G5 a me G7, ʻo ia ka mea like me ka lāʻau lapaʻau anti-hepatoma lāʻau lapaʻau sorafenib;Eia kekahi, ua hōʻike ʻo artemisinin G7 hema i ka koho maikaʻi a me ka palekana ma mua o ka sorafenib no THLE-2 i loko o nā puʻupuʻu ate maʻamau;I ka manawa like, hiki i ka artemisinin G7 hema ke pale i ka hoʻonui ʻana o nā cell HepG2 ma ke kāohi ʻana i ka hoʻouka ʻana a me ka neʻe ʻana o nā cell hepatoma, e hoʻoulu ai i ka apoptosis a me ka pale ʻana i ka pōʻai cell G2 / M.

Ua hōʻike ʻia kēia noiʻi no ka manawa mua i kahi moʻo o nā dimer sesquiterpene me ka ʻiʻo hou a me nā ʻano hana like ʻole i Artemisia annua, hoʻonui i nā ʻano hana o nā dimer sesquiterpene i nā mea kanu Artemisia, a hāʻawi i nā ʻano mole mole a me nā kumu lāʻau lapaʻau koʻikoʻi no ka noiʻi ʻana i nā anti anti hou. - nā lāʻau hepatoma.

I kēia lā, ua hoʻokaʻawale a ʻike ka hui noiʻi o Chen Jijun i 122 novel sesquiterpenoid dimer me ka hana anti-hepatoma mai Artemisia australis, Artemisia sinica, Artemisia medinalis, Artemisia cowtail a me Artemisia mongolica, e helu ana no 52% o ka huina o 234 dimer sesquiterpenoid i hōʻike ʻia e Nā mea kanu Artemisia i ka honua.

ʻO JinDun Medicalloaʻa i ka hui noiʻi ʻepekema lōʻihi a me ka grafting ʻenehana me nā kulanui Kina.Me nā waiwai lapaʻau waiwai o Jiangsu, loaʻa iā ia nā pilina kālepa lōʻihi me India, Asia Hema, South Korea, Iapana a me nā mākeke ʻē aʻe.Hāʻawi pū ia i nā lawelawe mākeke a me ke kūʻai aku i ke kaʻina holoʻokoʻa mai waena a hiki i ka huahana huahana API.E hoʻohana i nā kumuwaiwai i hōʻiliʻili ʻia o Yangshi Chemical i loko o ka kemika fluorine e hoʻolako i nā lawelawe hana hana kemika kūikawā no nā hoa.Hāʻawi i nā lawelawe noiʻi kaʻina hana a me ka haumia i nā mea kūʻai aku.

Ke koi nei ʻo JinDun Medical i ka hoʻokumu ʻana i kahi hui me nā moeʻuhane, hana i nā huahana me ka hanohano, meticulous, rigorous, a hele i nā mea a pau e lilo i hoa hilinaʻi a me ka hoaaloha o nā mea kūʻai aku! ʻoihanahana lāʻau lapaʻau maʻamau(CMO) a me nā mea lawelawe R&D lāʻau lapaʻau maʻamau a me ka hana (CDMO).